The heart of KYLANE LABORATOIRES is innovation. We rigorously strive to be the pioneer in discovery and development of the next generation of advanced Hyaluronic Acid solutions.
From its inception, the DNA of KYLANE LABORATOIRES is entirely based on innovation. Innovation is not just a concept; it is our mindset in all aspect of our approach.
Backed by facts infused in every link of the chain of KYLANE’s activities, innovation lies at the core of the Research & Development of our products, through to the Sales & Marketing and including the Manufacturing Operations and Quality.
We believe that there is still a large room for innovation to improve clinical outcomes and patient’s journey. With the progress of science, new solutions aim to be more attentive in regard to the safety & effectiveness.
At KYLANE LABORATOIRES, we believe that HA molecule is the best biopolymer to fill soft tissues. As a natural key component of the human body, HA is the “gold standard” in facial treatments, with limited applications and uses in body contour enhancement treatments. The reason is the lack of appropriate solutions meeting demanding clinical expectations.
Based on such gap analysis, our entire Research & Development capacity is devoted to providing cutting-edge solutions in full collaboration with the medical community.
At KYLANE LABORATOIRES, we believe that innovation starts by engaging with scientists, members of the medical community and patients. We partner with international thoughts leaders in order to capture better unmet needs and wishes for new solutions.
Building on this market knowledge, KYLANE LABORATOIRES is dedicated to scientific development for aesthetics and medical applications. This commitment is supported by research programs and scientific publications made in collaboration with physicians and scientists worldwide.
Through our deep and accurate market knowledge, our cutting-edge science, and our unique expertise in the HA field, KYLANE LABORATOIRES can truly translate ideas into innovative medical solutions.
When a fresh, groundbreaking idea is considered innovative and relevant for the patients and physicians, we work harder than ever to develop this solution to create a brand new product for the market.
A constructive and iterative process is then implemented with our physicians and scientists to develop the innovative HA device features.
KYLANE LABORATOIRES has created the innovative OXIFREE™ proprietary technology which offers a progressive and forward-thinking collection of unique facial fillers which are extremely advanced and safe, and also customized for each indication.
The OXIFREE™ manufacturing technology is characterized by the extraction of destructive oxygen during the manufacturing process, including the crosslinking step, in order to significantly preserve the intrinsic properties of the long molecular weight of Hyaluronic Acid chains.
This new technology provides safe HA fillers demonstrating outstanding projection capacities to sculpt, volumize and define precisely the facial contours.
KYLANE LABORATOIRES has created the innovative RHEOPURE™ proprietary technology, to design a new innovative product for the Medical Aesthetics market: a non-surgical* body filler that enables to redefine and enhance the body’s contours harmoniously.
The RHEOPURE™ manufacturing technology is characterized by the highly efficient and accurate crosslinking of long molecular weight of Hyaluronic Acid chains thanks to a guided crosslinking reaction process, combined with a XXL purification of the crosslinked gel.
This cutting-edge technology offers optimal elasticity & projection capacity for shaping contours and excellent tissue integration of the gel for high safety treatment.
*non-surgical means, in this context, that the injection of the product into the tissues doesn't require to be used in operating room.